1) Phthisis and the Arts
2) Global Epidemiology of Tuberculosis
3) Tuberculosis Epidemiology-United States
4) Molecular Epidemiology
5) Tuberculosis Latency
6) Comparative Genomics
7) Genetic Diversity of M. tuberculosis
8) Tuberculosis Latency/ Persistence
9) M. tuberculosis Cell Wall
10) M.tuberculosis Virulence
11) Laboratory Diagnosis
12) Rapid Diagnostic Tests
13) Immunodiagnosis
14) Innate Immunity/ NRAMP
15) Phagocytosis/ Toll Receptors
16) NO
17) Animal Models
18) Cell Mediated Immune Response
19) CD1 Response
20) Dendritic Cells
21) Cytokine Response
22) Molecular Mechanisms of TB/HIV Interaction in the Lung
23) Apoptosis
24) Pulmonary Tuberculosis
25) Radiology of Tuberculosis
26) Mycobacteria and the Human
27) Pathology
28) Pleural Tuberculosis
29) Miliary Tuberculosis
30) Surgical Treatment of Tuberculosis
31) Pericardial Tuberculosis
32) Ocular Complications
33) Tuberculosis of the Head, Neck and Oral Cavity
34) Tuberculous Lymphadenitis
35) Tuberculous Meningitis
36) Tuberculosis of the Genitourinary Tract
37) Tuberculosis of the Gastrointestinal Tract
38) Pott's Disease
39) Musculoskeletal Tuberculosis
40) Endocrine and Metabolic Manifestations of Tuberculosis
41) Mycobacteria and the Skin
42) Tuberculosis in Children
43) Tuberculosis and Pregnancy and Tuberculous Mastitis
44) Nontuberculous Mycobacterial Infections in the HIV-Negative
Host
45) MAC and Other Non TB mycobacterial Infections in HIV
Infected Patients
46) Principles of Treatment Directly Observed Therapy Multi-drug
Resistant Tuberculosis
47) MDR TB
48) Isoniazid
49) Rifampin/ Rifabutin/ Rifapentene
50) Pyrazinamide, Ethambutal, Ethionamide and Aminoglycosides
51) Fluoroquinolones
52) Pharmacokinetics of Antituberculosis Drugs
53) Pharmacogenomics and Tuberculosis Structure
54) Tuberculin Skin Test
55) Health Care Facilities/ Worker
56) International Organizations and Tuberculosis
57) BCG Efficacy and Immunity
58) Tuberculosis Vaccine Science
59) Tuberculosis Elimination